Exelixis Insider Alert: Julie Smith Buys 86,500 Shares at a 40% Discount Amid Executive Sell‑Offs—A Possible Confidence Signal?
Julie Smith’s bulk buys at Exelixis reveal insider confidence – buy‑back at $18‑$19, well below market, signaling potential upside amid exec sales and a biotech pipeline poised for milestones.
3 minutes to read